Philippe Lamy
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- Epigenetics and DNA Methylation 16
- RNA modifications and cancer 9
- Circular RNAs in diseases 7
-
- Cancer Genomics and Diagnostics 13
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 11
- Co-authors
- Lars Dyrskjøt (29 shared papers)Torben F. Ørntoft (21 shared papers)Claus L. Andersen (17 shared papers)Iver Nordentoft (21 shared papers)Michael Borre (10 shared papers)Karin Birkenkamp‐Demtröder (15 shared papers)Marie S. Ostenfeld (4 shared papers)Jørgen Bjerggaard Jensen (16 shared papers)
- Journals
- International Journal of Cancer (5 papers)Cancer Research (5 papers)Clinical Cancer Research (4 papers)European Urology (4 papers)Oncogene (3 papers)
- Partner nations
- DenmarkUnited StatesSwitzerland
In The Last Decade
Philippe Lamy
51 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 1.3k
- Molecular Biology 1.7k
- Surgery 815
- Oncology 466
- Pulmonary and Respiratory Medicine 476
Countries citing papers authored by Philippe Lamy
This map shows the geographic impact of Philippe Lamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Lamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Lamy more than expected).
Fields of papers citing papers by Philippe Lamy
This network shows the impact of papers produced by Philippe Lamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Lamy. The network helps show where Philippe Lamy may publish in the future.
Co-authors
The 25 scholars most cited alongside Philippe Lamy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 315 | |
| 2 | 2017 | 230 | |
| 3 | 2011 | 169 | |
| 4 | 2020 | 135 | |
| 5 | 2011 | 133 | |
| 6 | 2011 | 128 | |
| 7 | 2009 | 125 | |
| 8 | 2017 | 122 | |
| 9 | 2014 | 110 | |
| 10 | 2013 | 108 | |
| 11 | 2016 | 93 | |
| 12 | 2013 | 88 | |
| 13 | 2017 | 82 | |
| 14 | 2016 | 68 | |
| 15 | 2012 | 65 | |
| 16 | 2011 | 63 | |
| 17 | 2017 | 62 | |
| 18 | 2011 | 52 | |
| 19 | 2022 | 39 | |
| 20 | 2006 | 39 |
About Philippe Lamy
Philippe Lamy is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 56 papers that have together received 2.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (22 papers), Epigenetics and DNA Methylation (16 papers), Cancer Genomics and Diagnostics (13 papers), MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (9 papers), Circular RNAs in diseases (7 papers) and Genetic factors in colorectal cancer (6 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (1.7k citations), Surgery (815 citations), Oncology (466 citations) and Pulmonary and Respiratory Medicine (476 citations). Philippe Lamy has collaborated with scholars based in Denmark, United States and Switzerland. Frequent co-authors include Lars Dyrskjøt, Torben F. Ørntoft, Claus L. Andersen, Iver Nordentoft, Michael Borre, Karin Birkenkamp‐Demtröder, Marie S. Ostenfeld, Jørgen Bjerggaard Jensen, Søren Vang and S. Høyer. Their work appears in journals such as International Journal of Cancer, Cancer Research, Clinical Cancer Research, European Urology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.